Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where José Tormo is active.

Publication


Featured researches published by José Tormo.


The EMBO Journal | 1996

Crystal structure of a bacterial family-III cellulose-binding domain: a general mechanism for attachment to cellulose.

José Tormo; Raphael Lamed; A J Chirino; Ely Morag; Edward A. Bayer; Yuval Shoham; T A Steitz

The crystal structure of a family‐III cellulose‐binding domain (CBD) from the cellulosomal scaffoldin subunit of Clostridium thermocellum has been determined at 1.75 A resolution. The protein forms a nine‐stranded beta sandwich with a jelly roll topology and binds a calcium ion. conserved, surface‐exposed residues map into two defined surfaces located on opposite sides of the molecule. One of these faces is dominated by a planar linear strip of aromatic and polar residues which are proposed to interact with crystalline cellulose. The other conserved residues are contained in a shallow groove, the function of which is currently unknown, and which has not been observed previously in other families of CBDs. On the basis of modeling studies combined with comparisons of recently determined NMR structures for other CBDs, a general model for the binding of CBDs to cellulose is presented. Although the proposed binding of the CBD to cellulose is essentially a surface interaction, specific types and combinations of amino acids appear to interact selectively with glucose moieties positioned on three adjacent chains of the cellulose surface. The major interaction is characterized by the planar strip of aromatic residues, which align along one of the chains. In addition, polar amino acid residues are proposed to anchor the CBD molecule to two other adjacent chains of crystalline cellulose.


The EMBO Journal | 1998

Structure of the foot-and-mouth disease virus leader protease: a papain-like fold adapted for self-processing and eIF4G recognition.

Alba Guarné; José Tormo; Regina Kirchweger; Doris M. Pfistermueller; Ignacio Fita; Tim Skern

The leader protease of foot‐and‐mouth disease virus, as well as cleaving itself from the nascent viral polyprotein, disables host cell protein synthesis by specific proteolysis of a cellular protein: the eukaryotic initiation factor 4G (eIF4G). The crystal structure of the leader protease presented here comprises a globular catalytic domain reminiscent of that of cysteine proteases of the papain superfamily, and a flexible C‐terminal extension found intruding into the substrate‐binding site of an adjacent molecule. Nevertheless, the relative disposition of this extension and the globular domain to each other supports intramolecular self‐processing. The different sequences of the two substrates cleaved during viral replication, the viral polyprotein (at LysLeuLys↓GlyAlaGly) and eIF4G (at AsnLeuGly↓ArgThrThr), appear to be recognized by distinct features in a narrow, negatively charged groove traversing the active centre. The structure illustrates how the prototype papain fold has been adapted to the requirements of an RNA virus. Thus, the protein scaffold has been reduced to a minimum core domain, with the active site being modified to increase specificity. Furthermore, surface features have been developed which enable C‐terminal self‐processing from the viral polyprotein.


Structure | 1995

Crystal structure of catalase HPII from Escherichia coli

Jerónimo Bravo; Núria Verdaguer; José Tormo; Christian Betzel; Jack Switala; Peter C. Loewen; Ignacio Fita

BACKGROUND Catalase is a ubiquitous enzyme present in both the prokaryotic and eukaryotic cells of aerobic organisms. It serves, in part, to protect the cell from the toxic effects of small peroxides. Escherichia coli produces two catalases, HPI and HPII, that are quite distinct from other catalases in physical structure and catalytic properties. HPII, studied in this work, is encoded by the katE gene, and has been characterized as an oligomeric, monofunctional catalase containing one cis-heme d prosthetic group per subunit of 753 residues. RESULTS The crystal structure of catalase HPII from E. coli has been determined to 2.8 A resolution. The asymmetric unit of the crystal contains a whole molecule, which is a tetramer with accurate 222 point group symmetry. In the model built, that includes residues 27-753 and one heme group per monomer, strict non-crystallographic symmetry has been maintained. The crystallographic agreement R-factor is 20.1% for 58,477 reflections in the resolution shell 8.0-2.8 A. CONCLUSIONS Despite differences in size and chemical properties, which were suggestive of a unique catalase, the deduced structure of HPII is related to the structure of catalase from Penicillium vitale, whose sequence is not yet known. In particular, both molecules have an additional C-terminal domain that is absent in the bovine catalase. This extra domain contains a Rossmann fold but no bound nucleotides have been detected, and its physiological role is unknown. In HPII, the heme group is modified to a heme d and inverted with respect to the orientation determined in all previously reported heme catalases. HPII is the largest catalase for which the structure has been determined to almost atomic resolution.


Journal of Biological Chemistry | 2001

Crystal Structure of the C-type Lectin-like Domain from the Human Hematopoietic Cell Receptor CD69

Andrea S. Llera; Fernando Viedma; Francisco Sánchez-Madrid; José Tormo

CD69, one of the earliest specific antigens acquired during lymphoid activation, acts as a signal-transducing receptor involved in cellular activation events, including proliferation and induction of specific genes. CD69 belongs to a family of receptors that modulate the immune response and whose genes are clustered in the natural killer (NK) gene complex. The extracellular portion of these receptors represent a subfamily of C-type lectin-like domains (CTLDs), which are divergent from true C-type lectins and are referred to as NK-cell domains (NKDs). We have determined the three-dimensional structure of human CD69 NKD in two different crystal forms. CD69 NKD adopts the canonical CTLD fold but lacks the features involved in Ca2+ and carbohydrate binding by C-type lectins. CD69 NKD dimerizes noncovalently, both in solution and in crystalline state. The dimer interface consists of a hydrophobic, loosely packed core, surrounded by polar interactions, including an interdomain β sheet. The intersubunit core shows certain structural plasticity that may facilitate conformational rearrangements for binding to ligands. The surface equivalent to the binding site of other members of the CTLD superfamily reveals a hydrophobic patch surrounded by conserved charged residues that probably constitutes the CD69 ligand-binding site.


Journal of Immunology | 2000

Mapping the Ligand of the NK Inhibitory Receptor Ly49A on Living Cells

Doo Hyun Chung; Kannan Natarajan; Lisa F. Boyd; José Tormo; Roy A. Mariuzza; Wayne M. Yokoyama; David H. Margulies

We have used a recombinant, biotinylated form of the mouse NK cell inhibitory receptor, Ly49A, to visualize the expression of MHC class I (MHC-I) ligands on living lymphoid cells. A panel of murine strains, including MHC congenic lines, was examined. We detected binding of Ly49A to cells expressing H-2Dd, H-2Dk, and H-2Dp but not to those expressing other MHC molecules. Cells of the MHC-recombinant strain B10.PL (H-2u) not only bound Ly49A but also inhibited cytolysis by Ly49A+ effector cells, consistent with the correlation of in vitro binding and NK cell function. Binding of Ly49A to H-2Dd-bearing cells of different lymphoid tissues was proportional to the level of H-2Dd expression and was not related to the lineage of the cells examined. These binding results, interpreted in the context of amino acid sequence comparisons and the recently determined three-dimensional structure of the Ly49A/H-2Dd complex, suggest a role for amino acid residues at the amino-terminal end of the α1 helix of the MHC-I molecule for Ly49A interaction. This view is supported by a marked decrease in affinity of an H-2Dd mutant, I52 M, for Ly49A. Thus, allelic variation of MHC-I molecules controls measurable affinity for the NK inhibitory receptor Ly49A and explains differences in functional recognition in different mouse strains.


Journal of Molecular Biology | 1994

Investigation of shape variations in the antibody binding site by molecular dynamics computer simulation

Xavier de la Cruz; Alan E. Mark; José Tormo; Ignacio Fita; Wilfred F. van Gunsteren

Molecular dynamics simulations have been used to investigate the flexibility and variations in the shape of the binding site of an antibody against human Rhinovirus serotype 2 (HRV2) and its complex with a 15 amino acid oligopeptide, the structure of which has been recently determined by X-ray crystallography. During the simulation of the unbound antibody the binding site, defined in terms of the hypervariable regions or complementarity determining regions (CDRs), shows significant fluctuations in shape. For the complex such variations in the shape of the binding site were reduced. The largest fluctuations in the unbound antibody occurred within the CDR-H3. The largest differences between the bound and unbound crystal structures are also associated with CDR-H3. The relative displacements of the loops have been analysed in terms of internal distortions, rigid body motions of the loops and changes with respect to the framework regions. The degree to which the motions of the loops are correlated and the variation in the volume of the binding pocket during the simulation have also been examined.


Biochemistry | 2000

Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface.

Eric J. Sundberg; Mariela Urrutia; Bradford C. Braden; Jordi Isern; Daisuke Tsuchiya; Barry A. Fields; Emilio L. Malchiodi; José Tormo; Frederick P. Schwarz; Roy A. Mariuzza


Journal of Molecular Biology | 2000

Structural and biochemical features distinguish the foot-and-mouth disease virus leader proteinase from other papain-like enzymes

Alba Guarné; Bernhard Hampoelz; Walter Glaser; Xavier Carpena; José Tormo; Ignacio Fita; Tim Skern


Journal of Biological Chemistry | 2001

Binding of the Natural Killer Cell Inhibitory Receptor Ly49A to Its Major Histocompatibility Complex Class I Ligand

Jian Wang; Mary C. Whitman; Kannan Natarajan; José Tormo; Roy A. Mariuzza; David Michael Margulies


Journal of Molecular Biology | 1994

Crystallization and Preliminary X-ray Analysis of the Major Cellulose-binding Domain of the Cellulosome from Clostridium thermocellum

Raphael Lamed; José Tormo; Arthur J. Chirino; Ely Morag; Edward A. Bayer

Collaboration


Dive into the José Tormo's collaboration.

Top Co-Authors

Avatar

Ignacio Fita

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar

Kannan Natarajan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Alba Guarné

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar

Jerónimo Bravo

Polytechnic University of Catalonia

View shared research outputs
Top Co-Authors

Avatar

Núria Verdaguer

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar

David H. Margulies

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jian Wang

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Edward A. Bayer

Weizmann Institute of Science

View shared research outputs
Researchain Logo
Decentralizing Knowledge